Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
Site référencé: Raw Story
Raw Story
Critics shred JD Vance as he shrugs off millions losing Medicaid as 'minutiae'
1er/07/2025
‘Totally illegal !' Kristi Noem aims to prosecute CNN over ICE report
1er/07/2025
'Wasn't going to make a difference' : Senate leader's advice to holdout revealed
1er/07/2025
'Abomination !' Outrage hits senators as they pass bill in razor-thin vote
1er/07/2025
'Get them the hell out' : Trump says deporting US citizens could be 'next job'
1er/07/2025
Jasmine Crockett lights up GOP for passing 'uglier than before' megabill
1er/07/2025
